Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
UK public sector net debt: Out of control?
By
Nigel Hawkins
07 Jul 2021
International Biotechnology Trust
Life Sciences
Investing in a broad spectrum of the drug industry
By
Dr Martin Hall
06 Jul 2021
The Monthly: July 2021
02 Jul 2021
Tissue Regenix
Life Sciences
Poised for growth
By
Dr Martin Hall
30 Jun 2021
Palace Capital
Property
Dividend recovery ahead of expectations
By
Mike Foster
21 Jun 2021
Par Fund Management (Fund)
Technology
Par EIS Fund
By
Dr Brian Moretta
09 Jun 2021
Agriculture
Cannabis – a blooming industry
By
Yingheng Chen
04 Jun 2021
The Monthly: June 2021
01 Jun 2021
CyanConnode
Technology
Major announcement in India with IntelliSmart
By
Milan Radia
27 May 2021
Shield Therapeutics Plc
Life Sciences
Accrufer® launch on schedule
By
Dr Martin Hall
26 May 2021
Oakley Capital Investments
Investment Companies
2021 Capital Markets day: proof of the pudding
By
Mark Thomas
25 May 2021
Prev
1
...
31
32
33
34
35
...
84
Next
